Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report By Application (New Born Screening, Infectious Disease Testing, Forensics), By Card Type, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global dried blood spot collection cards market size was valued at USD 371.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030. The market for dried blood spot (DBS) collection cards is estimated to witness moderate growth during the forecast period in spite of their primary use in newborn screening, increasing adoption in forensic toxicology applications, and growing affiliations between private and public organizations to develop diagnostic products.

The COVID-19 pandemic has created an operational threat on dried blood spot collection cards, along with demand-side opportunities for pharmaceutical companies and institutions. Relevant organizations and companies are studying and understanding this new infectious virus to advance treatments and diagnostic tools against it through dried blood spot collection cards. For instance, a study to determine the feasibility of a commercial COVID-19 assay to measure the level of antibodies from dried blood spot collection cards was conducted by the University of Toronto, University Health Network, Viral Hepatitis Care Network, and other individual authors. The study found that plasma on dried blood spot collection cards offered near-identical results to plasma samples, helping detect antibodies in 88% of people’s plasma.

Dried blood spot collection cards are a complementary product to DBS testing; hence rally in the demand for testing is expected to have a cascading effect on the dried blood spot collection cards. Dried blood spot collection cards are highly preferable in laboratories and other testing centers in rural areas since the cost is low, which allows health personnel to take multiple tests for accurate results. Hence, rising initiatives by various government organizations, private-public partnerships or collaborations for enhancing usage, and spreading awareness regarding diagnostic products are likely to boost the market demand in the coming years. For instance, the government of India proposed to develop the healthcare infrastructure across the country, including setting up combined public health laboratories in the majority of the districts, 3,382 units of block public in 11 states, critical care hospital blocks in 12 central institutions, and 602 districts. Along with this, 17,000+ rural and 11,000+ urban health and wellness centers will be supported.

However, technical obstacles while collecting blood samples from the geriatric population through dried blood spot collection cards can obstruct the growth of the market. For instance, research conducted by De Montfort University states that micro-sampling methods were able to successfully identify the correct drugs for patients. It concluded that dried blood spot collection cards could be a difficult method for the geriatric population as they fail to implement the procedure accurately by placing the drop of blood outside the selected area.

Furthermore, it has been observed that dried blood spot collection cards are susceptible to cross-contamination or contamination by users, the environment, the equipment, and other collection cards during sample processing. The majority of these concerns can be mitigated by proper care and handling. The majority of these risks are typically mitigated through the adoption of standard operating procedures and safety laboratory accessories.

Application Insights

The New Born Screening (NBS) segment dominated of dried blood spot collection cards market with a share of 24.27% in 2022. Increasing newborn screening is considered to be a significant growth factor in this market. For instance, according to the National Organization for Rare Disorders, it is estimated that around 4 million infants were screened in the U.S. in 2021 through drops of blood from the heel of the newborn prior to discharge from a hospital or birth center since the prevalence rate of certain metabolic errors, endocrinopathies, and hearing loss is high and can significantly contribute to morbidity.

Similarly, in May 2022, NHS England updated the guidance newborn blood spot (NBS) screening service for cystic fibrosis (CF) in the U.K. The guidance is considered a reference handbook for labs. The standard protocol includes IRT analysis based on an initial dried blood sample.

Similarly, the increasing use of dried blood spot collection card applications, such as forensic toxicology applications, compelled various players to innovate an efficient and cost-effective process. In research conducted by Simões et al. in August 2021, dried blood spot collection cards proved to be useful in detecting illicit drugs. The use of these cards also facilitates increased sample stability, allowing samples to be stored for a longer duration, thereby creating a safer work environment for analysts and sample collectors, as only a small sample volume is a requirement.

Card Type Insights

Whatman 903 held the largest market share of 31.89% in dried blood spot collection cards market in 2022, as it is efficient and safe for sample identification, collection, and transport. Whatman paper is a specialized type of filter paper used extensively in qualitative analysis. The filter paper contains cellulose fibers and is manufactured using high-quality cotton linters. Thus, Whatman filter papers contain a higher proportion of alpha-cellulose, giving it consistency and quality. Growing usage of the Whatman card type in various research studies is another major factor expected to significantly impact market growth in the near future.

For instance, in June 2022, a group of researchers from the Division of Vector-Borne Diseases, Fort Collins, conducted a study to assess the Whatman FTA cards use in molecular diagnosis for detecting Yellow fever virus (YFV). The study conducted that the card can be easy to use and cost-effective in molecular diagnosis of yellow fever. Additionally, it enables the clinician to preserve viral RNA without a cold chain.

Furthermore, an increase in the utilization of Ahlstrom cards in various research studies focused on the diagnosis of diseases and other clinical applications is another major factor expected to propel the market growth during the forecast period. In March 2020, a research study published in Frontiers in Microbiology aimed at using dried blood spot tests for therapeutic monitoring and diagnosis of viral hepatitis B & C and HIV.

Regional Insights

North America dominated the dried blood spot (DBS) collection cards market and reported the largest revenue share of 35.28% in 2022. The region is likely to continue a similar trend over the projected period. This growth can be attributed to the acceleration in government initiatives for newborn screening tests along with the growing research to expand the utility of DBS collection cards in various applications.

In the U.S., every baby born is required to be screened as a part of standard medical procedures, although the cost of newborn screening tests varies from state to state as each state's finance allocation is different. The screening expenses are reimbursed by health insurance or other programs. Hence, irrespective of healthcare insurance status, babies will receive the screening.

The Asia-Pacific market is expected to witness the fastest CAGR of 4.7% over the projected period. The key growth factors in the market are the presence of a large target population in countries, such as India, China, Japan, and South Korea. In addition, the growing adoption of innovative laboratory techniques and procedures such as dried blood spot collection cards for faster investigation and diagnosis of infectious and chronic disorders is one of the key factors driving the regional market.

Key Companies & Market Share Insights

The market is highly competitive with the presence of many established and emerging players. Roche, Qiagen, PerkinElmer, Shimadzu Corporation, and Danaher are some of the established players in the market, which accounted for a significant revenue share in 2021. Since the global market is highly fragmented, public companies account for a small market share compared to small private players.

Key players adopt different growth strategies, such as new product development, product differentiation, and expansion of geographical reach to capture larger shares in the market. For instance, in July 2020, PerkinElmer launched a dried blood spot collection cards-based COVID-19 serology test by using GSP/DELFIA Platform, which enables 5,000 samples for processing. Some prominent players in the global dried blood spot collection cards market include:

• QIAGEN

• Perkinelmer

• Roche

• Shimadzu Corporation

• Ahlstrom-Munksjö

• Pall Corporation

• Eastern Business Forms, Inc.

• Archimed Life Science GmbH

• Centogene N.V.

Dried Blood Spot Collection Cards Market Report Scope

Global Dried Blood Spot Collection Cards Market Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the dried blood spot collection cards on the basis of application, card type, and region.

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • New Born Screening (NBS)

  • Infectious Disease Testing

  • Therapeutic Drug Monitoring

  • Forensics

  • CRO/Research

  • Other Applications

• Card Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Whatman 903

  • Ahlstrom 226

  • FTA

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Singapore

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait